Hims & Hers faces lawsuit over allegedly deceptive weight loss medication sales.
ByAinvest
Monday, Aug 4, 2025 8:51 am ET1min read
HIMS--
The complaint alleges that during the class period, Hims & Hers Health Inc. issued materially false and/or misleading statements and failed to disclose that:
1. The company was engaged in the "deceptive promotion and selling of illegitimate, knockoff versions of Wegovy® that put patient safety at risk" [2].
2. There was a substantial risk that the company's collaboration with Novo Nordisk would be terminated.
3. Defendants' positive statements about the company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
Shareholders are encouraged to contact the Gross Law Firm before August 25, 2025, to discuss their rights [1]. The firm offers portfolio monitoring software to provide shareholders with status updates throughout the case's lifecycle. There is no cost or obligation to participate in the case.
The Gross Law Firm is a nationally recognized class action law firm committed to protecting investors' rights. The firm seeks recovery on behalf of shareholders who incurred losses due to false and/or misleading statements or the omission of material information [1].
References:
[1] https://www.prnewswire.com/news-releases/hims--hers-health-inc-sued-for-securities-law-violations---contact-the-gross-law-firm-before-august-25-2025-to-discuss-your-rights--hims-302520050.html
[2] https://www.marketscreener.com/news/hims-hers-health-inc-sued-for-securities-law-violations-contact-the-gross-law-firm-before-augu-ce7c5edadf8bfe20
NVO--
The Gross Law Firm is seeking shareholders of Hims & Hers Health to contact them regarding possible lead plaintiff appointment. The firm alleges that the company issued false and/or misleading statements during the class period of April 29, 2025 to June 23, 2025, including deceptive promotion and selling of illegitimate versions of Wegovy and a substantial risk that the company's collaboration with Novo Nordisk would be terminated. Shareholders are encouraged to contact the firm regarding possible lead plaintiff appointment.
NEW YORK, Aug. 4, 2025 /PRNewswire/ — The Gross Law Firm has issued a notice to shareholders of Hims & Hers Health Inc. (NYSE: HIMS), alleging securities law violations. The firm is seeking shareholders who purchased shares during the class period from April 29, 2025, to June 23, 2025, to contact them regarding possible lead plaintiff appointment [1].The complaint alleges that during the class period, Hims & Hers Health Inc. issued materially false and/or misleading statements and failed to disclose that:
1. The company was engaged in the "deceptive promotion and selling of illegitimate, knockoff versions of Wegovy® that put patient safety at risk" [2].
2. There was a substantial risk that the company's collaboration with Novo Nordisk would be terminated.
3. Defendants' positive statements about the company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
Shareholders are encouraged to contact the Gross Law Firm before August 25, 2025, to discuss their rights [1]. The firm offers portfolio monitoring software to provide shareholders with status updates throughout the case's lifecycle. There is no cost or obligation to participate in the case.
The Gross Law Firm is a nationally recognized class action law firm committed to protecting investors' rights. The firm seeks recovery on behalf of shareholders who incurred losses due to false and/or misleading statements or the omission of material information [1].
References:
[1] https://www.prnewswire.com/news-releases/hims--hers-health-inc-sued-for-securities-law-violations---contact-the-gross-law-firm-before-august-25-2025-to-discuss-your-rights--hims-302520050.html
[2] https://www.marketscreener.com/news/hims-hers-health-inc-sued-for-securities-law-violations-contact-the-gross-law-firm-before-augu-ce7c5edadf8bfe20
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet